- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.05. | Bristol Myers unveils data for one of its next-gen blood cancer drugs | ||
| 29.05. | Replimune takes third swing at cancer drug approval following 'productive' FDA talks | ||
| 29.05. | Allogene CEO to step down; Agios drug fails key test | ||
| 29.05. | Can a chaotic FDA still deliver on faster drug development? | ||
| 29.05. | Pfizer, Innovent strike $10B cancer drug deal | ||
| 28.05. | GSK, Ionis unveil data for hepatitis B drug touted as 'functional cure' | ||
| 28.05. | CVS obesity drug deal puts Lilly on equal footing with Novo | ||
| 27.05. | Verge, following trial failure, rebrands its AI drug discovery ambitions | ||
| 27.05. | FDA delays decision on AstraZeneca breast cancer pill | ||
| 27.05. | Cardio drugmaker Kardigan plans to go public | ||
| 27.05. | Kailera's three-pronged obesity shot shows promise in early trial | ||
| 27.05. | Apogee eczema drugs gets Blackstone backing, heads to Phase 3 | ||
| 26.05. | Early data for heart drug affirm Lilly's billion-dollar bet on Verve | ||
| 26.05. | Lilly dives into vaccine research with 3 biotech buyouts | ||
| 26.05. | Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine | ||
| 26.05. | SR One's Simeon George on how China is rewriting biotech's venture playbook | ||
| 26.05. | Process intensification: Separating fact from fiction | ||
| 26.05. | Measuring what matters: New priorities in COA selection | ||
| 22.05. | ASCO26: 5 data snapshots ahead of the year's biggest cancer drug meeting | ||
| 22.05. | Parkinson's drug from Biogen, Denali comes up short | ||
| 21.05. | RA Capital banks $75M for a biotech SPAC | ||
| 21.05. | Lilly's triple-acting obesity drug hits goal in Phase 3 trial | ||
| 21.05. | BioMarin notches win in study that could expand use of top-selling medicine | ||
| 21.05. | In Alzheimer's, Bristol Myers sees big promise beyond amyloid | ||
| 20.05. | After raising $800M, Parabilis seeks an IPO to pursue 'undruggable' targets |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.